Evidence map›Paper›PMID 33046006›Full record

ArticleBMC microbiology2020

The combined usage of Matrine and Osthole inhibited endoplasmic reticulum apoptosis induced by PCV2.

Yinlan Xu, Panpan Sun, Shuangxiu Wan, Jianhua Guo, Xiaozhong Zheng, Yaogui Sun, Kuohai Fan, Wei Yin, Na Sun, Hongquan Li

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. The Antiviral Potential ofMolecules (Basel, Switzerland) · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Yinlan XuCollege of Veterinary Medicine, Shanxi Agricultural University, Taigu, 030801, Shanxi, China.
Panpan SunLaboratory Animal Center, Shanxi Agricultural University, Taigu, 030801, Shanxi, China.
Shuangxiu WanCollege of Veterinary Medicine, Shanxi Agricultural University, Taigu, 030801, Shanxi, China.
Jianhua GuoDepartment of Veterinary Pathobiology, Schubot Exotic Bird Health Center, Texas A&M University, College Station, Texas, TX, 77843, USA.
Xiaozhong ZhengMedical Research Council (MRC) Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, EH16 4TJ, UK.
Yaogui SunCollege of Veterinary Medicine, Shanxi Agricultural University, Taigu, 030801, Shanxi, China.
Kuohai FanLaboratory Animal Center, Shanxi Agricultural University, Taigu, 030801, Shanxi, China.
Wei YinCollege of Veterinary Medicine, Shanxi Agricultural University, Taigu, 030801, Shanxi, China.
Na SunCollege of Veterinary Medicine, Shanxi Agricultural University, Taigu, 030801, Shanxi, China.
Hongquan LiCollege of Veterinary Medicine, Shanxi Agricultural University, Taigu, 030801, Shanxi, China. livets@163.com.
Shanxi Agricultural University · CNTexas A&M University · USUniversity of Edinburgh · GB

Funding

Graduate Education Innovation Project of Shanxi Province 2019BY065Shanxi Province Science Foundation for Excellent Youths 201801D211003the National Key R&D Program of China 2017YFD0501500
6 · The paper itself

Abstract

backgroundPorcine circovirus type 2 (PCV2) is an important and common DNA virus that infect pig and can cause immunosuppression and induce apoptosis in the infected cells. To escape the host immune system, PCV2 constantly builds up complex mechanisms or mutates genes, and that is why it is difficult to eradicate complex PCV2 infection by relying on vaccines and single compound. At present, there is few literature reports on the effective prevention and treatment of PCV2 infection by a combination of two or more compounds. Previously, we have demonstrated the anti-PCV2 effect of Matrine in vitro, but its mechanism has not been further evaluated. Literatures have proven that Osthole has a variety of pharmacological activities, and we tested the ability of Osthole to inhibit PCV2 replication in cell culture. Therefore, this study explored the synergistic antiviral effect of Matrine combined with Osthole and their synergistic anti-apoptotic mechanism.

resultsOsthole alone had an anti-PCV2 effect, and then its synergistic anti-PCV2 effect of Osthole and Matrine was better than that of Matrine or Osthole alone as demonstrated by qRT-PCR, IFA and Western blotting results. The anti-apoptotic mechanism of these two compounds by inducing the PERK pathway by PCV2 was elucidated through Annexin V-FITC/PI, JC-1 and Western blotting. Matrine and Osthole combination could inhibit the expression of Cap in Cap-transfected PK-15 cells, thus inhibiting Cap-induced PERK apoptosis. Ribavirin was used as a positive control.

conclusionsThe combination of Osthole and Matrine had the synergistic effect of anti-PCV2 infection by directly inhibiting the expression of PCV2 Cap protein. The combination of these two compounds also inhibited PERK apoptosis induced by PCV2 Cap protein, possibly by regulating the level of GRP78. The results formed a base for further studies on the mechanism of anti-PCV2 in vivo using Matrine and Osthole combination and developing new anti-PCV2 compounds with Cap and GRP78 as therapeutic targets.

Indexed as

Activating Transcription Factor 4AlkaloidsAnimalsAntiviral AgentsApoptosisCaspase 3Cell LineCircovirusCoumarinsDrug CombinationsDrug SynergismeIF-2 KinaseEndoplasmic ReticulumEndoplasmic Reticulum Chaperone BiPEpithelial CellsEukaryotic Initiation Factor-2Activating Transcription Factor 4AlkaloidsAntiviral AgentsCaspase 3CoumarinsDrug CombinationseIF-2 KinaseEndoplasmic Reticulum Chaperone BiPEukaryotic Initiation Factor-2Heat-Shock ProteinsMatrinesostholProto-Oncogene Proteins c-bcl-2QuinolizinesTranscription Factor CHOPViral ProteinsApoptosisCapGRP78MatrineOstholePCV2

Identifiers

PMID33046006
PMCPMC7549248
OpenAlexW3092216222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.